EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

THE EFFICIENCY OF ANTI C1Q ANTIBODY AS A DIAGNOSTIC TOOL IN SLE PATIENTS WITH PROLIFERATIVE LUPUS NEPHRITIS

Dr. Salina Akter*, Dr. Mohammad Rafiqul Alam, Dr. Abdullah Al Mamun, Dr. Md. Siddiqur Rahman, Dr. Md Kawsarul Islam and Md. Ajfar Sazid Khan

ABSTRACT

Objective: In this study our main goal is to evaluate the efficiency of Anti C1q antibody as a diagnostic tool in SLE patients with proliferative lupus nephritis. Method: This cross-sectional analytic study was conduct at Departments of Nephrology and Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladeshfrom July 2014 to June 2016. 72 patients were recruited for this study of which the case group was consisted of 36 patients. The rest 36 patients were in the control group. Results: During the study, blood pressure was significantly higher among cases than controls. Mild anaemia in case and control groups were found in 15 (41.7%) and 17 (47.2%) patients respectively. Moderate anaemia was present within case and control groups in 13 (36.1%) and 11 (30.6%) patients respectively. The difference in case and control group regarding anaemia was not statistically significant (p=0.962). Level of anti C1q antibody was significantly higher in patients with low serum C4. Similarly, anti C1q antibody level was higher in patients with low serum C3 and positive anti-ds DNA. anti C1q-antibody level was significantly higher in case than that of control. The mean Anti C1q-antibody in case and control group were 37.04 ± 30.01 ng/ml and 4.76 ± 9.16 ng/ml with the range of 1.09 – 123.00 ng/ml and 0.04 – 40.04 ng/ml with the p value of less than 0.001. Conclusion: We can conclude that, anti-C1q antibody along with other biomarkers of lupus nephritis (anti dsDNA, C3 and C4) greatly improves the diagnosis of active lupus nephritis in patients with SLE.

Keywords: Anti C1q antibody, systemic lupus erythematosus (SLE), autoimmune disease.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • EJPMR OCTOBER ISSUE PUBLISHED

    OCTOBER 2020 Issue has been successfully launched on 1 October 2020.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 September 2020 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing